Flagship Pioneering
$1.5B 13F equity value
5 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Flagship Pioneering covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| GENB | GENERATE BIOMEDICINES INC | 62,673,117 | $1.1B | 68.7% |
| MRNA | MODERNA INC | 4,632,149 | $324M | 21.1% |
| SANA | SANA BIOTECHNOLOGY INC | 25,001,856 | $87M | 5.7% |
| FHTX | FOGHORN THERAPEUTICS INC | 12,674,120 | $62M | 4.0% |
| MCRB | SERES THERAPEUTICS INC | 1,155,850 | $9M | 0.6% |
Track Flagship Pioneering's 13F portfolio: $1.5B in reported holdings, 5 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}